Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study.

Shunji EndoTetsuji TerazawaMasahiro GotoRyo TanakaTakeshi KatoKazumasa FujitaniHisato KawakamiDaisuke SakaiYukinori KurokawaToshimasa TsujinakaToshio ShimokawaTaroh Satoh

Published in: BMC cancer (2022)

Registered with Japan Registry of Clinical Trials on October 11, 2019 ( jRCTs051190060 ).

Keyphrases

phase ii study
locally advanced
clinical trial
rectal cancer
open label
squamous cell carcinoma
randomized controlled trial
lymph node
phase ii